Plasma Rich in Growth Factors in Post-extraction Sockets
NCT: NCT03943680 · COMPLETED
NCT IDNCT03943680
StatusCOMPLETED
Start Date2019-03-04
Completion2025-10-30
Brief Summary
The purpose of this study is to compare the clinical success, radiographical volume maintenance and histological bone regeneration after using either a bovine bone xenograft or an autogenous platelet rich plasma enrich in growth factors, known as Endoret®-PRGF®.
Frequently Asked Questions
What is Plasma Rich in Growth Factors in Post-extraction Sockets?
Plasma Rich in Growth Factors in Post-extraction Sockets is a clinical trial registered under NCT03943680. Current status: COMPLETED.
What is the status of NCT03943680?
The current status of NCT03943680 (Plasma Rich in Growth Factors in Post-extraction Sockets) is: COMPLETED.
When did Plasma Rich in Growth Factors in Post-extraction Sockets start?
Plasma Rich in Growth Factors in Post-extraction Sockets started on 2019-03-04.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.